Articles

The AAD has provided various at-home treatments for keratosis pilaris that physicians can recommend to their patients. 

At-Home Treatment Recommendations for Keratosis Pilaris

From oat oil to acupuncture to prebiotics, there are many topical, oral, and manual options. 

How to Choose Integrative AD Therapies  

Patients with anxiety/depression and psoriatic arthritis (PsA) are much less likely to achieve long-term remission. Mental health comorbidities need to be a more important part of PsA treatment.  

Mental Health Affects Psoriatic Arthritis Treatment

Explore what dermatologic drugs the FDA will decide to approve during July 2021.

July FDA Approvals to Watch

Vivace microneedling device receives FDA clearance on 2MHz radiofrequency setting.

 ABM Vivace Receives 2MHz FDA Clearance

New TrichoTest aims to help clinicians diagnose and treat alopecia.  

First Genetic Test for Hair Loss

A higher prevalence of vitamin D deficiency in people of color may be contributing to a higher burden of COVID-19 in minority populations. Dermatologists are encouraged to address vitamin D status in patients and recommend supplementation, which might have other health benefits. 

COVID-19 Increases Urgency of Addressing Vitamin D Deficiencies in Patients With Skin of Color

Videos

John Browning, MD, FAAD, FAAP, MBA, discusses the impact of the recent FDA approval of secukinumab (Cosentyx, Novartis) for the treatment of moderate to severe plaque psoriasis in children and adolescents.

Secukinumab Approved for Plaque Psoriasis in Children, Adolescents

Sunscreen is a necessary preventive tool. However, there are concerns about UV agent absorption, environmental impact, and possible correlations with frontal fibrosing alopecia (FFA). Here is a look at whether those worries are justified by research. 

Debunking Sunscreen Controversies

Recent therapeutic advances in topical and systemic therapy offer new options for cases that have not responded to established treatment approaches.

NP and PA